Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.65 GBX
-2.67%
Market Closed
Updated:
Apr 29, 2024
Fusion Antibodies PLC
Research & Development
|
Fusion Antibodies PLC
Research & Development Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Research & Development
-£607k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Research & Development
-£103.8m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Research & Development?
Research & Development
-607k
GBP
-607k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Research & Development amounts to -607k GBP.
What is Fusion Antibodies PLC's Research & Development growth rate?
Research & Development CAGR 3Y
-31%
-31%
Over the last year, the Research & Development growth was 17%. The average annual Research & Development growth rates for Fusion Antibodies PLC have been -31% over the past three years .
You don't have any saved screeners yet
